Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JCO Clinical Cancer Informatics is Scopus-indexed (Q2, CiteScore 4.8), WoS ESCI. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 2473-4276Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 166 / 428 | 61st | Q2 |
| Health Informatics | 73 / 168 | 56th | Q2 |
| Cancer Research | 134 / 233 | 42nd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q2, CiteScore 4.8.
JCO Clinical Cancer Informatics is Q2 in Oncology (rank 166 of 428), Q2 in Health Informatics (rank 73 of 168) and Q3 in Cancer Research (rank 134 of 233), by CiteScore 2025.
JCO Clinical Cancer Informatics is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.8, which places it in quartile Q2 at the 61st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.174, quartile Q1, with an H-index of 46.
JCO Clinical Cancer Informatics is published by Lippincott Williams and Wilkins. Its ISSN is 2473-4276.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
JCO Clinical Cancer Informatics has an h-index of 56 and a 2-year mean of 2.68 citations per paper (OpenAlex). Its Scopus CiteScore is 4.8, quartile Q2. On 2-year citations it ranks #134 of 424 Scopus journals in Oncology.
JCO Clinical Cancer Informatics published 179 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from United States (60.7%), Switzerland (4.1%) and Netherlands (4.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.